Patents by Inventor Catherine Rugg

Catherine Rugg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210253722
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 12, 2021
    Publication date: August 19, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210221899
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 5, 2021
    Publication date: July 22, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210221898
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 5, 2021
    Publication date: July 22, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210214449
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 3, 2021
    Publication date: July 15, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210214451
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 15, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210214450
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 15, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210198373
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 10, 2021
    Publication date: July 1, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20210188988
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: March 9, 2021
    Publication date: June 24, 2021
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF antibodies and methods thereof
    Patent number: 10982002
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: April 20, 2021
    Assignee: Zoetis Services LLC
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Anti-NGF Antibodies and Methods Thereof
    Publication number: 20190276548
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: January 18, 2019
    Publication date: September 12, 2019
    Inventors: Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
  • Substituted dihydro-isoindolones useful in treating kinase disorders
    Publication number: 20070161648
    Abstract: The present invention is directed to novel substituted dihydro-isoindolone compounds of formula (I): and forms thereof, wherein Ring A, X3, R1, R2, R3, R4 and R6 are as herein defined, and their synthesis and use as protein kinase inhibitors and interactions thereof.
    Type: Application
    Filed: October 13, 2006
    Publication date: July 12, 2007
    Inventors: Terry Hughes, Stuart Emanuel, Catherine Rugg, Peter Connolly